|
|
Volumn 23, Issue 6, 2009, Pages 613-614
|
|
Commentary on STAR*D: A summary and UK perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CITALOPRAM;
LITHIUM;
PLACEBO;
ANTIDEPRESSANT AGENT;
CLINICAL RESEARCH;
CLINICAL TRIAL;
COGNITIVE THERAPY;
COMORBIDITY;
DEPRESSION;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FOLLOW UP;
HAMILTON SCALE;
HUMAN;
NOTE;
OUTCOME ASSESSMENT;
OUTPATIENT;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
REMISSION;
TREATMENT OUTCOME;
UNITED KINGDOM;
METHODOLOGY;
PROSPECTIVE STUDY;
PSYCHOLOGICAL ASPECT;
RANDOMIZATION;
STATISTICAL ANALYSIS;
ANTIDEPRESSIVE AGENTS;
DATA INTERPRETATION, STATISTICAL;
DEPRESSIVE DISORDER;
GREAT BRITAIN;
HUMANS;
PROSPECTIVE STUDIES;
RANDOM ALLOCATION;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
|
EID: 67651163697
PISSN: 02698811
EISSN: 14617285
Source Type: Journal
DOI: 10.1177/0269881109104888 Document Type: Note |
|
Times cited : (2)
|
|
References (5)
|
